Evidence map›Paper›PMID 24142469›Full record

ArticleWorld journal of microbiology & biotechnology2014

Recombinant xylanase from Streptomyces coelicolor Ac-738: characterization and the effect on xylan-containing products.

Alexander V Lisov, Oksana V Belova, Zhanna I Andreeva-Kovalevskaya, Zhanna I Budarina, Alexander A Solonin, Nataliya G Vinokurova, Alexey A Leontievsky

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Expression inInternational journal of molecular sciences · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexander V LisovG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Russian Academy of Sciences (IBPM RAS), 5 Prospekt Nauki, 142290, Pushchino, Moscow Region, Russia, ssl204@rambler.ru.
Oksana V Belova
Zhanna I Andreeva-Kovalevskaya
Zhanna I Budarina
Alexander A Solonin
Nataliya G Vinokurova
Alexey A Leontievsky
G. K. Skryabin Institute of Biochemistry and Physiology of Microorganisms · RUPushchino State Institute of Natural Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A xylanase gene was isolated from the genomic DNA of Streptomyces coelicolor Ac-738. The 723-bp full-length gene encoded a 241-amino acid peptide consisting of a 49-residue putative TAT signal peptide and a glycoside hydrolase family-11 domain. The mature enzyme called XSC738 was expressed in Escherichia coli M15[pREP4]. The electrophoretically homogeneous protein with a specific activity of 167 U/mg for beechwood xylan was purified. The pH optimum of XSC738 was at pH 6; a high activity was retained within a pH range of 4.5-8.5. The enzyme was thermostable at 50-60 °C and retained an activity at pH 3.0-7.0. Xylanase XSC738 was activated by Mn²⁺, Co²⁺ and largely inhibited by Cd²⁺, SDS and EDTA. The products of xylan hydrolysis were mainly xylobiose, xylotriose, xylopentaose and xylohexose. Xylotetraose appeared as a minor product. Processing of such agricultural xylan-containing products as wheat, oats, soy flour and wheat bran by xylanase resulted in an increased content of sugars.

Indexed as

AvenaEnzyme ActivatorsEnzyme InhibitorsEnzyme StabilityEscherichia coliGene ExpressionHydrogen-Ion ConcentrationMetalsMolecular WeightRecombinant ProteinsStreptomyces coelicolorTemperatureTriticumXylansXylosidasesEnzyme ActivatorsEnzyme InhibitorsMetalsRecombinant ProteinsXylansXylosidases

Identifiers

PMID24142469
OpenAlexW2062239149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.